99855-02-4 Usage
Uses
Used in Pharmaceutical Industry:
3-(2,3-Dihydro-1H-indol-1-yl)propanoic acid is used as a precursor in the synthesis of various pharmaceuticals for its potential to exhibit biological activities. 3-(2,3-DIHYDRO-1H-INDOL-1-YL)PROPANOICACID's indole structure is known to be associated with a range of pharmacological effects, which could be harnessed for the development of new drugs.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-(2,3-Dihydro-1H-indol-1-yl)propanoic acid is utilized as a starting material for the design and synthesis of novel compounds with potential therapeutic applications. Its structural features allow for modifications that could enhance or direct its biological activity towards specific targets.
Used in Drug Development:
3-(2,3-Dihydro-1H-indol-1-yl)propanoic acid is employed in drug development as a lead compound for the discovery of new therapeutic agents. Its indole-based structure may possess properties such as anticancer, antibacterial, and antidepressant activities, which are valuable for treating a variety of medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 99855-02-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,8,5 and 5 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 99855-02:
(7*9)+(6*9)+(5*8)+(4*5)+(3*5)+(2*0)+(1*2)=194
194 % 10 = 4
So 99855-02-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H13NO2/c13-11(14)6-8-12-7-5-9-3-1-2-4-10(9)12/h1-4H,5-8H2,(H,13,14)
99855-02-4Relevant academic research and scientific papers
Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists
Wu, Lingyun,Lu, Kai,Packiarajan, Mathivanan,Jubian, Vrej,Chandrasena, Gamini,Wolinsky, Toni C.,Walker, Mary W.
, p. 2167 - 2171 (2012/04/18)
A novel series of indolyl and dihydroindolyl glycinamides were identified as potent NPY5 antagonists with in vivo activity from screen hit 1. The dihydroindolyl glycinamide 10a significantly inhibits NPY5 agonist induced feeding at a dose of 0.1 mg/kg. The indolyl glycinamide 12c also inhibits NPY5 agonist induced feeding at a dose of 1 mg/kg. Both compounds 10a and 12c represent potential tools for further investigation into the biology of the NPY5 receptor.
